A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 in Children (6-11 Years) With Attention Deficit Hyperactivity Disorder (ADHD)

Name: A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 in Children (6-11 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
Published: 2009
License: Public Domain

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · 2009

ClinicalTrials.gov · Datasets · License: Public Domain · 2009

Open Source ↗

adhd attention-deficit-hyperactivity-disorder

attention deficit hyperactivity disorder, attention deficit disorders with hyperactivity, adhd, jnj-31001074, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 in Children (6-11 Years) With Attention Deficit Hyperactivity Disorder (ADHD)

Related documents